Playback speed
10 seconds
ASCO GI 2023 Phase Ib OBERTO-201 Study: Evaluating Safety, Tolerability, Immunogenicity, & Efficacy of Multiple Subcutaneous Injections of PolyPEPI1018 Vaccine as an Add-On IO to TAS-102 in Late-Stage MSS mCRC
By
ASCO GI 2023 Conference Coverage
FEATURING
Joleen Hubbard
By
ASCO GI 2023 Conference Coverage
FEATURING
Joleen Hubbard
34 views
February 3, 2023
Login to view comments.
Click here to Login